Ueno Ryuji 4
4 · Sucampo Pharmaceuticals, Inc. · Filed Sep 13, 2017
Insider Transaction Report
Form 4
Ueno Ryuji
DirectorCEO, Chief Scientific Officer10% Owner
Transactions
- Sale
Class A Common Stock
2017-09-11$12.00/sh−1,000,000$12,000,000→ 8,006,585 total(indirect: By LLC)
Footnotes (1)
- [F1]On September 11, 2017, the reporting person sold 1,000,000 shares through a block trade pursuant to Rule 144 under the Securities Act of 1933, as amended.